CPT 3395F refers to the quantitative non-HER2 immunohistochemistry (IHC) evaluation of breast cancer, specifically focusing on the testing for estrogen...
Home / Articles / CPT / Category II /
Category II - Page 42
CPT 3115F refers to a specific evaluation that provides quantitative results regarding a patient’s current level of activity and clinical...
CPT 0520F refers to the establishment of radiation dose limits to normal tissues prior to the initiation of a course...
CPT 6045F pertains to the documentation of radiation exposure or exposure time in the final report for procedures utilizing fluoroscopy....
CPT 6005F refers to the documentation of the rationale for the level of care provided to a patient, such as...
CPT 0528F refers to the recommended follow-up interval for repeat colonoscopy, specifically indicating that a follow-up should occur at least...
CPT 4051F refers to the process of being referred for an arteriovenous (AV) fistula, specifically in the context of patients...
CPT 4500F refers to the referral of a patient to an outpatient cardiac rehabilitation program specifically for individuals diagnosed with...
CPT 1160F refers to the comprehensive review of all medications by a prescribing practitioner or clinical pharmacist. This process involves...
CPT 3265F refers to ribonucleic acid (RNA) testing for Hepatitis C viremia, a critical diagnostic procedure used to detect the...
CPT 3218F refers to RNA testing for Hepatitis C, a critical diagnostic procedure that assesses the presence of the Hepatitis...
CPT 3754F refers to the process of screening tests for diabetes mellitus that have been reviewed, requested, or ordered. This...